Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 2 1

Status

Completed 5Terminated 1

Sponsor Class

OTHER 6INDUSTRY 6NIH 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Genitourinary 32Thoracic 9Gastrointestinal 9Tumor-Agnostic 6Other solid neoplasm 4Gynecologic 3Head & Neck 2Dermatologic 2Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1CNS 1Breast 1

Conditions

Neoplasms 4Carcinoma 3

Interventions

pembrolizumab 62Paclitaxel 51Gemcitabine 50Carboplatin 45Docetaxel 43Cisplatin 31Pemetrexed 30Nivolumab 28Bevacizumab 28atezolizumab 22Fluorouracil 22Cetuximab 21Capecitabine 21Irinotecan 20Leucovorin 19Afatinib 18Erlotinib Hydrochloride 15trametinib 14Trastuzumab 13Ipilimumab 13130-nm albumin-bound paclitaxel 13regorafenib 11olaparib 11Sorafenib 11Oxaliplatin 11Drug Therapy 11eribulin 10enzalutamide 10Midazolam 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Axitinib × Tumor-Agnostic × Clear all
NCT05097599 2025-01-08

StrataPATH

Strata Oncology

Phase 2 Terminated
11 enrolled
Tumor-Agnostic

Neoplasms

NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Pfizer

Completed
684 enrolled 20 charts
Tumor-Agnostic

Carcinoma, Neoplasms

NCT01999972 2020-09-24

A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
50 enrolled 29 charts
Tumor-Agnostic

Carcinoma

NCT00447005 2012-05-23

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Completed
12 enrolled 16 charts
Tumor-Agnostic

Carcinoma

NCT00726752 2012-05-23

A Study In Patients With Advanced Solid Tumor

Pfizer

Phase 1 Completed
6 enrolled 16 charts
Tumor-Agnostic

Neoplasms

NCT00454649 2012-04-04

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Pfizer

Phase 1 Completed
102 enrolled 48 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡